M&A Activity Shifts To Niche Purchases

Indian pharmaceutical and healthcare companies are turning their backs on large overseas purchases and are buying smaller firms, which are both cheaper and easier to integrate into existing operations. The downturn in the global economy and the subsequent heightened acuity of private equity players has been attributed as the main reason behind the trend. BMI agrees but also believes that the increasing number of strategic purchases is due to a dearth of attractive targets, especially in Western

To read the full article, please choose one of the following options: